During the past decade, Celerion conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 7 clinical trials were completed, i.e. on average, 26.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 5 clinical trials were completed. i.e. 55.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Celerion" #1 sponsor was "Philip Morris Products S.A." with 3 trials, followed by "Celtaxsys, Inc." with 2 trials sponsored, "Proteostasis Therapeutics, Inc." with 2 trials sponsored, "AbbVie" with 1 trials sponsored and "Alexion" with 1 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Celerion" #1 collaborator was "Celerion" with 5 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Celerion Ltd" with 1 trials as a collaborator, "European Commission" with 1 trials as a collaborator and "Imperial Brands PLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Celerion" are "Cystic Fibrosis" (10 trials), "Healthy" (3 trials), "Smoking" (3 trials), "Asthma" (2 trials) and "Healthy Subjects" (2 trials). Many other conditions were trialed in "Celerion" in a lesser frequency.

Most popular intervention types in "Celerion" are "Drug" (27 trials), "Other" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "CIG" (2 trials), "CTX-4430" (2 trials), "PTI-428" (2 trials) and "ACT-389949 (Group C1 dose to be selected)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Celerion" are 31 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Celerion". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Celerion, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Celerion, 22 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".